Medco looks to increase adherence for hep C patients

07/7/2011 | Zacks

Accredo Health Group, Medco's specialty pharmacy unit, will attempt to improve medication adherence of subscribers with hepatitis C through education and specialist interventions. New hepatitis C drugs boceprevir and teleprevir could bring treatment periods down to 24 weeks instead of the 48 weeks that other regimens require, but the process is complex and requires a high degree of adherence to work.

View Full Article in:

Zacks

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY